Angiotech offloads interventional devices to Argon

The lowdown

The lowdown

Angiotech Pharmaceuticals has agreed to sell its interventional products business to Argon Medical Devices for $362.5 million, in what appears...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight